A febrile thrombocytopenia is it always dengue

Putu Risma Yuvita Riadi; Ketut Suryana

doi:10.18203/2349-3933.ijam20242321

Authors

Putu Risma Yuvita Riadi Department of Internal Medicine, Wangaya Regional Hospital, Denpasar, Bali, Indonesia
Ketut Suryana Department of Internal Medicine, Wangaya Regional Hospital, Denpasar, Bali, Indonesia

DOI:

https://doi.org/10.18203/2349-3933.ijam20242321

Keywords:

Dengue, Febrile, Thrombocytopenia, HIV, Infection

Abstract

Dengue is tropic infectious disease which concentrated in tropical and subtropical regions. Human immunodeficiency virus (HIV) is an infection that attacks the body’s immune system. A 29-year-old female admitted to hospital with history of febrile thrombocytopenia with HIV infection on highly active anti-retroviral therapy (HAART). First, the patient was assessed with dengue hemorrhagic fever, but anti-dengue immunoglobulin G (IgG) and IgM were negative. Febrile thrombocytopenia occurs not only in dengue, but also in other conditions. Person with HIV experience a wide range of hematological abnormalities, the most prevalent of which are cytopenias, which can be anemia, leukopenia, thrombocytopenia, or a combination of these. Fever and thrombocytopenia are closely related to dengue infection, but this condition can also be caused by various factors.

Metrics

Metrics Loading ...

References

Khetarpal N, Khanna I. Dengue fever: causes, complications, and vaccine strategies. J Immunol Res. 2016;1-14.

Gubler DJ. Dengue and Dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11.

Wang WH, Urbina AN, Chang MR, Assavalapsakul W, Lu PL, Chen YH, et al. Dengue hemorrhagic fever-A systemic literature review of current perspectives on pathogenesis, prevention and control. J Microbiol Immunol Infect. 2020;53(6):963-78.

Htun TP, Xiong Z, Pang J. Clinical signs and symptoms associated with WHO severe dengue classification: a systematic review and meta-analysis. Emerg Microbes Infect. 2021;10(1):1116-28.

HIV-Global. Cited 2024. Available at. https://www.who.int/health-topics/hiv-aids. Accessed on 12th March 2024.

Deeks SG, Overbaugh J, Phillips A, Buchbinder S. HIV infection. Nat Rev Dis Primer. 2015;1(1):15035.

Boniphace I. HIV/AIDS clinical manifestations and their implication for patient clinical staging in resource limited settings in Tanzania. Open AIDS J. 2011;5(1):9-16.

Nascimento FG, Tanaka PY. Thrombocytopenia in HIV-Infected Patients. Indian J Hematol Blood Transfus. 2012;28(2):109-11.

Dengue virus infection: Clinical manifestations and diagnosis. cited 2024. Available at. https://medilib.ir.

Ng DH, Wong JG, Thein TL, Leo YS, Lye DC. The Significance of Prolonged and Saddleback Fever in Hospitalised Adult Dengue. PLoS ONE. 2016;11(12):167025.

Obeagu E, Nwosu D. Adverse drug reactions in HIV/AIDS patients on highly active antiretro viral therapy: a review of prevalence. 2019;6:45–8.

Opie J, Verburgh E, Bailly J, Mayne E, Louw V. Hematological complications of Human Immunodeficiency Virus (HIV) Infection: An Update From an HIV-Endemic Setting. Open Forum Infect Dis. 2024;11(4):162.

Getawa S, Aynalem M, Bayleyegn B, Adane T. The global prevalence of thrombocytopenia among HIV-infected adults: A systematic review and meta-analysis. Int J Infect Dis. 2021;105:495–504.

Shen Y, Wang J, Wang Z, Shen J, Qi T, Song W, et al. A cross-sectional study of leukopenia and thrombocytopenia among Chinese adults with newly diagnosed HIV/AIDS. Biosci Trends. 2015;9(2):91-6.

Raadsen M, Du Toit J, Langerak T, Van Bussel B, Van Gorp E, Goeijenbier M. Thrombocytopenia in Virus Infections. J Clin Med. 2021;10(4):8.